Clinical Trials Insight: 700020249
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2008
At a glance
- Drugs Ozarelix (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Spectrum Pharmaceuticals
- 23 Apr 2008 Status change from in progress to completed, according to Spectrum Pharmaceuticals.
- 22 Apr 2008 Results reported by Spectrum Pharmaceuticals, announced in an AEterna Zentaris media release.
- 01 May 2007 Status change from initiated to in progress